SOPHiA GENETICS マネジメント
マネジメント 基準チェック /34
SOPHiA GENETICS' CEO is Jurgi Camblong, appointed in Mar 2011, has a tenure of 13.67 years. directly owns 3.72% of the company’s shares, worth $8.95M. The average tenure of the management team and the board of directors is 4.3 years and 4.4 years respectively.
主要情報
Jurgi Camblong
最高経営責任者
n/a
報酬総額
CEO給与比率 | n/a |
CEO在任期間 | 13.7yrs |
CEOの所有権 | 3.7% |
経営陣の平均在職期間 | 4.3yrs |
取締役会の平均在任期間 | 4.4yrs |
経営陣の近況
Recent updates
Is SOPHiA GENETICS (NASDAQ:SOPH) A Risky Investment?
Oct 03SOPHiA GENETICS SA (NASDAQ:SOPH) Just Reported, And Analysts Assigned A US$6.00 Price Target
Aug 09Investors Still Waiting For A Pull Back In SOPHiA GENETICS SA (NASDAQ:SOPH)
Aug 08SOPHiA GENETICS SA (NASDAQ:SOPH) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Mar 09Sophia Genetics: Breakthrough Potential In A Cautious Healthcare Sector
Feb 12Here's Why We're Not Too Worried About SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation
Dec 27Why Investors Shouldn't Be Surprised By SOPHiA GENETICS SA's (NASDAQ:SOPH) 35% Share Price Surge
Nov 09Is SOPHiA GENETICS (NASDAQ:SOPH) In A Good Position To Invest In Growth?
Aug 08Here's Why We're Watching SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation
Dec 15SOPHiA GENETICS partnering with Boundless Bio on oncogene cancer therapies
Sep 21SOPHiA Genetics GAAP EPS of -$0.39 in-line, revenue of $11.7M misses by $0.25M
Aug 09We're Hopeful That SOPHiA GENETICS (NASDAQ:SOPH) Will Use Its Cash Wisely
Jul 01SOPHiA GENETICS SA (NASDAQ:SOPH) Just Reported Earnings, And Analysts Cut Their Target Price
Mar 18We Think SOPHiA GENETICS (NASDAQ:SOPH) Can Afford To Drive Business Growth
Mar 10Here's Why We're Not Too Worried About SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation
Nov 24CEO報酬分析
日付 | 総報酬 | 給与 | 会社業績 |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$67m |
Mar 31 2024 | n/a | n/a | -US$73m |
Dec 31 2023 | n/a | n/a | -US$79m |
Sep 30 2023 | n/a | n/a | -US$69m |
Jun 30 2023 | n/a | n/a | -US$78m |
Mar 31 2023 | n/a | n/a | -US$82m |
Dec 31 2022 | US$3m | US$507k | -US$87m |
Sep 30 2022 | n/a | n/a | -US$95m |
Jun 30 2022 | n/a | n/a | -US$93m |
Mar 31 2022 | n/a | n/a | -US$86m |
Dec 31 2021 | US$8m | US$394k | -US$74m |
報酬と市場: Insufficient data to establish whether Jurgi's total compensation is reasonable compared to companies of similar size in the US market.
報酬と収益: Jurgi's compensation has been consistent with company performance over the past year.
CEO(最高経営責任者
Jurgi Camblong (46 yo)
13.7yrs
在職期間
US$3,332,361
報酬
Dr. Jurgi Camblong, Ph D., M.B.A., serves as Chief Executive Officer and Director of SOPHiA GENETICS SA since March 2011. Dr. Camblong Co-founded SOPHiA GENETICS SA since March 2011.In 2010, Dr. Camblong...
リーダーシップ・チーム
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
Co-Founder | 13.7yrs | US$3.33m | 3.72% $ 9.0m | |
Executive VP | 3.8yrs | データなし | 0.093% $ 224.0k | |
Senior VP & CTO | 2.8yrs | データなし | データなし | |
Executive VP & Chief Scientific Officer | 3.8yrs | データなし | 0.63% $ 1.5m | |
Vice President of Investor Relations | no data | データなし | データなし | |
Executive VP | 5.4yrs | データなし | 0.14% $ 334.2k | |
Executive VP & Chief People Officer | 5.8yrs | データなし | 0.060% $ 145.2k | |
VP & MD of EMEA | 1.3yrs | データなし | データなし | |
Executive VP | 4.8yrs | データなし | 0.063% $ 152.0k |
4.3yrs
平均在職期間
44.5yo
平均年齢
経験豊富な経営陣: SOPH's management team is considered experienced (4.3 years average tenure).
取締役
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
Co-Founder | 13.7yrs | US$3.33m | 3.72% $ 9.0m | |
Independent Non-Executive Director | 3.8yrs | US$257.20k | 0.057% $ 136.2k | |
Independent Non-Executive Director | 4.4yrs | US$265.94k | 0.11% $ 271.3k | |
Independent Director | 2.8yrs | US$218.17k | 0.096% $ 230.8k | |
Independent Non-Executive Director | 10.4yrs | US$233.53k | 0.60% $ 1.4m | |
Independent Non-Executive Director | 3.7yrs | データなし | データなし | |
Independent Non-Executive Chairman | 5.4yrs | US$290.93k | 0.28% $ 676.8k |
4.4yrs
平均在職期間
60yo
平均年齢
経験豊富なボード: SOPH's board of directors are considered experienced (4.4 years average tenure).